IMUX · NASDAQ · Biotechnology

Immunic (IMUX)

Develops oral small-molecule candidates for multiple sclerosis and other inflammatory or autoimmune diseases.

$11.00
After hours+0.19 (+1.76%)
At close$10.81(−0.18%)